Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v5-EN
Language French English
Date Updated 2020-01-09 2020-01-09
Drug Identification Number 02210347 02210347
Brand name MYLAN-VERAPAMIL SR MYLAN-VERAPAMIL SR
Common or Proper name VERAPAMIL SR VERAPAMIL SR
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients VERAPAMIL HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE
Strength(s) 120MG 120MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BT 100 BT
ATC code C08DA C08DA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-08-06 2019-08-06
Estimated end date 2020-01-16 2019-12-20
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments